1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 37,380 | 38,500 | 10:15 | |
| 37,380 | 38,500 | 10:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Soleno: Studienergebnisse zur PWS-Behandlung in endokrinologischem Fachjournal veröffentlicht | 3 | Investing.com Deutsch | ||
| SOLENO THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| Mo | Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT XR in the Journal of Clinical Endocrinology and Metabolism | 197 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases... ► Artikel lesen | |
| 03.12.25 | Soleno Therapeutics: Verwaltungsratsmitglied William Harris verstorben | 4 | Investing.com Deutsch | ||
| 03.12.25 | Soleno Therapeutics Announces the Passing of Board Member William G. Harris | 3 | GlobeNewswire (USA) | ||
| 17.11.25 | Wolfe Research initiates Soleno Therapeutics stock with Outperform rating | 3 | Investing.com | ||
| 12.11.25 | SOLENO THERAPEUTICS INC - 8-K, Current Report | - | SEC Filings | ||
| 11.11.25 | Soleno Therapeutics Unveils $100 Million Buyback Citing 'Underappreciated' Future | 3 | Benzinga.com | ||
| 11.11.25 | Soleno Therapeutics announces entry into $100M accelerated share repurchase agreement | 2 | Seeking Alpha | ||
| 11.11.25 | Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement | 3 | GlobeNewswire (USA) | ||
| 06.11.25 | Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings | 2 | Insider Monkey | ||
| 05.11.25 | Soleno plunges despite Q3 beat as demand for Vykat XR cools | 3 | Seeking Alpha | ||
| 05.11.25 | Soleno slumps despite sales uptick; Madrigal's MASH drug continues ascent | 14 | BioPharma Dive | ||
| 05.11.25 | Soleno signals continued VYKAT XR market growth with net revenue doubling to $66M as European expansion advances | 8 | Seeking Alpha | ||
| 04.11.25 | SOLENO THERAPEUTICS INC - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 04.11.25 | SOLENO THERAPEUTICS INC - 8-K, Current Report | - | SEC Filings | ||
| 21.10.25 | Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET | 3 | GlobeNewswire (USA) | ||
| 16.10.25 | Soleno Therapeutics gains amind renewed takeover speculation | 3 | Seeking Alpha | ||
| 14.10.25 | SOLENO THERAPEUTICS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 07.10.25 | Soleno rated as new Buy at Goldman Sachs on Vykat XR potential | 2 | Seeking Alpha | ||
| 07.10.25 | Goldman Sachs initiates Soleno Therapeutics stock with Buy rating on Vykat potential | 2 | Investing.com |
1 2 3 4 Weiter >>
76 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,560 | +0,54 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,040 | -1,41 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,970 | +1,14 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| UNITEDHEALTH | 292,10 | -0,19 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| MEDTRONIC | 85,56 | +0,18 % | Medtronic Benefits Are Built for Every Chapter | Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare... ► Artikel lesen | |
| GERRESHEIMER | 27,340 | -1,30 % | Gerresheimer AG: Die Klarheit in der Rechnungslegung verbessert sich, aber die Vertrauenslücke bleibt bestehen. HALTEN. | Gerresheimer (GXI) hat das Kapitel der Bill-and-Hold-Buchhaltung abgeschlossen, indem etwa 28 Millionen EUR an Umsätzen für das Geschäftsjahr 2024 vollständig korrigiert wurden, nachdem eine von der... ► Artikel lesen | |
| INTUITIVE SURGICAL | 500,70 | -1,30 % | Is ISRG Stock Still A Buy At $600? | ||
| THERMO FISHER | 527,00 | -0,25 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| TELADOC HEALTH | 6,491 | +0,08 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| HIMS & HERS HEALTH | 30,380 | +0,03 % | Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization | ||
| BICO GROUP | 1,803 | -1,26 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,510 | -2,85 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 26,800 | +0,49 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | -0,90 % | Citizens reiterates Market Outperform rating on Privia Health stock | ||
| PROCEPT BIOROBOTICS | 33,920 | -2,28 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
Das Unternehmen SOLENO THERAPEUTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,020 (+0,05 %) liegt der Kurs bei 38,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SOLENO THERAPEUTICS INC finden Sie auf Wallstreet Online.